Aujourd'hui psychiatre libéral, ancien chef de clinique des hôpitaux, Guillaume Fond a publié plus d'une centaine d'articles scientifiques dans des revues internationales de psychiatrie, a participé à la rédaction d'ouvrage d'enseignement de psychiatrie et de psychopharmacologie et a dispensé des enseignements à la faculté de médecine Paris-Est et à l'université Pierre et Marie Curie-Paris VI.

Il a donné en 2017 un cours consacré au microbiote et à la santé à la faculté de médecine Pierre et Marie Curie - Paris VI.

Il poursuit ses recherches aux Centres experts Schizophrénie de la fondation Fondamental.

Ses travaux ont été récompensés par le prix de la meilleure publication en psychiatrie et par le congrès Européen de Neuropsychopharmacologie (ECNP).

Il a participé en 2017 à "Pint of Science", rencontres sur un thème scientifique entre un chercheur et le grand public, se tenant dans des bars.

Experience

  • 2017–present
    Intervenant, Université Pierre et Marie Curie
  • 2012–2016
    Enseignant-Chercheur associé, Université Paris-Est
  • 2010–2012
    Chef de clinique-Enseignant, Université Montpellier 1

Education

  • 2016 
    European congress of NeuroPsychopharmacology, Award meilleur publication en psychiatrie- catégorie jeune chercheur
  • 2016 
    Congrès Français de psychiatrie, Prix de la meilleure publication scientifique
  • 2011 
    Congrès de l'Encéphale- Paris, Prix du meilleur poster scientifique

Publications

  • 2017
    Advanced paternal age is associated with earlier schizophrenia onset in offspring. Results from the national multicentric FACE-SZ cohort., Psychiatry research
  • 2017
    Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data set., European Archives of Psychiatry and clinical Neuroscience
  • 2017
    Would I take antipsychotics, if I had psychotic symptoms? Examining determinants of the decision to take antipsychotics., Prog Neuropsychopharmacol Biol Psychiatry.
  • 2017
    Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset., European Archives of Psychiatry and clinical Neuroscience
  • 2017
    Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort., European Archives of Psychiatry and clinical Neuroscience
  • 2016
    Chronic Peripheral Inflammation is Associated With Cognitive Impairment in Schizophrenia: Results From the Multicentric FACE-SZ Dataset., Schizophrenia Bulle
  • 2016
    Medication and aggressiveness in "real world" schizophrenia: current issues and perspectives., Psychopharmacology (Berl)
  • 2016
    Differential effects of childhood trauma and cannabis use disorders in patients suffering from schizophrenia., Schizophrenia Research
  • 2016
    Birth by cesarean section and schizophrenia: results from the multicenter FACE-SZ data-set., European Archives of Psychiatry and clinical Neuroscience
  • 2016
    [Reflection on the psychiatric financial allocation in France]., Encephale
  • 2016
    C-reactive protein as a differential biomarker of bipolar II depression versus major depressive disorder., World J Biol Psychiatry
  • 2016
    Violent behavior and aggression in schizophrenia: Prevalence and risk factors. A multicentric study from three Latin-America countries., Schizophrenia Research
  • 2016
    Attitudes toward antipsychotic medications as a useful feature in exploring medication non-adherence in schizophrenia., Schizophrenia Research
  • 2016
    Interleukin-1 β-targeted treatment strategies in inflammatory depression: toward personalized care., Acta Psychiatrica Scandinavica
  • 2016
    Determination of Adherence Profiles in Schizophrenia Using Self-Reported Adherence: Results From the FACE-SZ Dataset., Journal of clinical Psychiatry
  • 2016
    Validation study of the Medication Adherence Rating Scale. Results from the FACE-SZ national dataset., Schizophrenia Research
  • 2016
    Childhood trauma, depression and negative symptoms are independently associated with impaired quality of life in schizophrenia. Results from the national FACE-SZ cohort., Schizophrenia Research
  • 2016
    Disparities in suicide mortality trends between United States of America and 25 European countries: retrospective analysis of WHO mortality database., Scientific Reports
  • 2016
    (Mis)use of Prescribed Stimulants in the Medical Student Community: Motives and Behaviors: A Population-Based Cross-Sectional Study., Medicine (Baltimore)
  • 2016
    Potentially inappropriate psychotropic prescription at discharge is associated with lower functioning in the elderly psychiatric inpatients. A cross-sectional study., Psychopharmacology (Berl)
  • 2015
    Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set., Journal of affective disorders
  • 2015
    Ketamine administration in depressive disorders: a systematic review and meta-analysis., Psychopharmacology (Berl)
  • 2015
    Do the treasures of 'big data' combined with behavioural intervention therapies contain the key to the mystery of large psychiatric issues?, Acta Psychiatrica Scandinavica
  • 2015
    Ketamine's effectiveness in unipolar versus bipolar depression., Psychopharmacology (Berl)
  • 2015
    The promise of biological markers for treatment response in first-episode psychosis: a systematic review., Schizophrenia Bulletin
  • 2015
    Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: a cross-sectional study., Journal of Psychiatric Research
  • 2015
    Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia., Schizophrenia Research
  • 2015
    Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis., Acta Psychiatrica Scandinavica
  • 2015
    Google Trends: Ready for real-time suicide prevention or just a Zeta-Jones effect? An exploratory study., Psychiatry research
  • 2015
    Mood disorders are associated with a more severe hypovitaminosis D than schizophrenia., Psychiatry research
  • 2015
    A National network of schizophrenia expert centres: An innovative tool to bridge the research-practice gap., European Psychiatry
  • 2015
    Innovative mechanisms of action for pharmaceutical cognitive enhancement: A systematic review., Psychiatry research
  • 2015
    Ketamine vs other anesthetic agents for electroconvulsive therapy (ECT) in major depression., Journal of Psychiatric Research
  • 2015
    Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort., Schizophrenia Research
  • 2015
    The World Health Organization (WHO) dataset for guiding suicide prevention policies: A 3-decade French national survey., Journal of affective disorders
  • 2015
    Akathisia: prevalence and risk factors in a community-dwelling sample of patients with schizophrenia. Results from the FACE-SZ dataset., Psychopharmacology (Berl)
  • 2015
    Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ dataset., Psychopharmacology (Berl)
  • 2015
    [The potential role of microbiota in major psychiatric disorders: Mechanisms, preclinical data, gastro-intestinal comorbidities and therapeutic options]., La Presse Medicale
  • 2015
    Pharmacoterrorism: the potential role of psychoactive drugs in the Paris and Tunisian attacks., Psychopharmacology (Berl)
  • 2015
    A Bayesian framework systematic review and meta-analysis of anesthetic agents effectiveness/tolerability profile in electroconvulsive therapy for major depression., Scientific Reports
  • 2014
    Nanopsychiatry--the potential role of nanotechnologies in the future of psychiatry: a systematic review., European NeuroPsychopharmacology
  • 2014
    Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysis., European Archives of Psychiatry and clinical Neuroscience
  • 2014
    D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: a metaregression analysis., Psychopharmacology (Berl)
  • 2014
    Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review., Acta Psychiatrica Scandinavica
  • 2014
    Comparative analysis of anti-toxoplasmic activity of antipsychotic drugs and valproate., European Archives of Psychiatry and clinical Neuroscience
  • 2014
    Fasting in mood disorders: neurobiology and effectiveness. A review of the literature., Psychiatry research

Honours

Prix de la meilleure publication en psychiatrie, Congrès Français de Psychiatrie, 2016